Vaxcell-Bio Therapeutics Logo

Vaxcell-Bio Therapeutics

Biotech firm developing immunotherapies for oncology and other diseases.

323990 | KO

Overview

Corporate Details

ISIN(s):
KR7323990002
LEI:
Country:
South Korea
Address:
전라남도 화순군 화순읍 산단길 12-55, 화순군

Description

Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of innovative immunotherapies. The company's primary focus is on oncology, developing a pipeline of cell-based and protein-based treatments, including immune cell therapies and targeted protein-degrading therapeutics. In addition to its core focus on cancer, Vaxcell-Bio is expanding its research into other areas, such as developing drug delivery system (DDS)-based therapies for conditions like macular degeneration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.4 KB
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2026-01-08 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2026-01-08 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 331.4 KB
2026-01-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 22.0 KB
2026-01-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-09-18 00:00
기업설명회(IR)개최
Korean HTML 6.9 KB
2025-09-17 00:00
투자판단관련주요경영사항 (박스루킨-15주 (Vaxleukin-15 inj) 품목허가 변경신청 승인)
Korean HTML 11.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.2 MB
2025-07-28 00:00
기업설명회(IR)개최
Korean HTML 7.9 KB
2025-06-24 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 126.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.2 MB
2025-04-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-04-08 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 17.0 KB
2025-04-08 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 17.1 KB

Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vaxcell-Bio Therapeutics

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.